Small Molecules Lead to a Big Change in Reaction Outcomes
News Sep 21, 2016
Yale scientists have found a way to rewire the behavior of an important group of small molecules involved in the synthesis of carbon-oxygen chemical bonds.
The process allows small, synthetic molecules to exhibit the functional diversity of much larger enzymatic catalysts, and offers a promising new tool for synthesizing therapeutics based on natural products. The findings appear in the journal ACS Central Science.
“In a sense, this is a miniaturization exercise,” said principal investigator Scott Miller, the Irénée du Pont Professor of Chemistry at Yale. “This is fundamental work in which we’re trying to control the way we make chemical bonds.”
A host of natural products exist that have beneficial properties for new drugs — yet many of them also have negative side effects. One of the challenges for researchers is to guide the action of catalysts in a way that alters the molecular structure of a target, like a natural product, to eliminate toxic effects while retaining beneficial properties.
Miller’s lab has been able to tune the bond-forming functions in peptide-based catalysts, which are similar to nature’s enzymes in that they are composed of amino acids, but are orders of magnitude simpler in terms of their molecular size. The researchers did this by changing the framework — or scaffolding — of the small, synthetic molecules. The new molecules are able to perform fundamentally different tasks, despite common catalytic fragments.
“We’ve created scaffolding that tailors a critical part of the catalyst,” Miller said. “We now hope to apply these ideas to modify the structures of biologically active products. It creates opportunities for doing quite complex synthesis.”
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Compound as Effective as FDA-Approved Drugs Against Life-Threatening InfectionsNews
Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.READ MORE
Chemists Design 'Mini-ecosystems' to Test Drug FunctionNews
Scripps Research scientists have solved a major problem in chemistry and drug development by using droplet-sized 'miniecosystems' to quickly see if a molecule can function as a potential therapeutic.READ MORE